Despite the widespread use of non-invasive indices such as the FLI, HSI, NAFLD-LFS, and AST/ALT ratio, their diagnostic performance remains inconsistent across various populations and diagnostic methods. Here, GPT is linked to metabolic dysfunction-associated steatotic liver disease.